Elevai Labs Inc. (NASDAQ:ELAB) does about 2.19M shares in volume on a normal day but saw 23036624 shares change hands in the recent trading day. The company now has a market cap of 2.21M USD. Its current market price is $0.11, marking a decrease of -62.00% compared to the previous close of $0.28. The 52 week high reached by this stock is $4.24 whilst the lowest price level in 52 weeks is $0.22.
Elevai Labs Inc. (ELAB) has a 20-day trading average at $0.2931 and the current price is -97.49% off the 52-week high compared with -51.08% distance from its 52-week low. The 50-day simple moving average of the closing price is $0.3489 and its 200-day simple moving average is $0.7525. If we look at the stock’s price movements over the week, volatility stands at 13.21%, which increases to 17.57% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 24.59 to suggest the stock is oversold.
The current price level is -64.90%, -70.18%, and -86.06% away from its SMA20, SMA50, and SMA200 respectively, with the ELAB price moving above the 50-day SMA on current market day. Elevai Labs Inc. (ELAB) stock is down -65.62% over the week and -53.25% over the past month. Its price is -94.18% year-to-date.
Outstanding shares total 17.33M with insiders holding 59.21% of the shares and institutional holders owning 0.75% of the company’s common stock. The company has a return on investment of -179.98%. Price to book ratio is 0.76 and price to sales ratio is 0.90.
